clinical development
- Health
LEO Pharma Presents Long-Term Safety and Efficacy Data for Tralokinumab in Adults With Moderate-to-Severe Atopic Dermatitis at AAD VMX 2021
Ballerup, Denmark & Madison, N.J., United States: Interim analysis at 56 weeks from ECZTEND, an open-label extension trial, demonstrates sustainable…
Read More » - Business Wire
LEO Pharma Receives Positive CHMP Opinion of Adtralza® (tralokinumab) for the Treatment of Adults With Moderate-to-Severe Atopic Dermatitis
NOT FOR DISTRIBUTION IN THE UK OR IRELAND If authorized, Adtralza® (tralokinumab) will be the first approved biologic that specifically…
Read More » - Health
APCER Strengthens Global Scientific Expertise With Appointment of Dr Taku Seriu as Senior Adviser to its Board
New Delhi, Delhi, India: APCER, a leading global Pharmacovigilance services company that brings together safety, medical, regulatory and technology resources to ensure that patients receive the…
Read More » - Business
Vifor Pharma to propose Dr Alexandre LeBeaut as Board member
St. Gallen, Switzerland: Dr Alexandre LeBeaut to be proposed to Annual General Meeting for appointment to Board Dr Gianni Zampieri…
Read More »